Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and e...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
AOSIS,
2022-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance. |
|---|---|
| Item Description: | 1608-9693 2078-6751 10.4102/sajhivmed.v23i1.1435 |